Trial
NCT04857840
Randomized Study of Extended Treatment With Firibastat in Treatment-Resistant Hypertension (REFRESH)
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Quantum Genomics SA
Collaborators
PRA Health Sciences
Condition
Hypertension (HTN)
Intervention
Firibastat (QGC001) Period 1
Why stopped
No Efficacy demonstrated inn the QGC001-3QG1 study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-17